Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United States/Retatrutide
Purchase and availability checkRetatrutide in the United States

Can you buy Retatrutide in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Retatrutide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United States
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Retatrutide in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Retatrutide is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Retatrutide in United States?

Resolve the exact identity of Retatrutide through TRIUMPH-1 Phase 3 study - NCT05929066 from ClinicalTrials.gov. Then search Drugs@FDA approved drug database from U.S. Food and Drug Administration for the destination product record and Locate a state-licensed online pharmacy from U.S. Food and Drug Administration for the seller, establishment, or supply route in United States. A match in one record does not replace the other two checks.

03

Does an online listing prove Retatrutide is authorized or available in United States?

No. A page using the name Retatrutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United States, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Retatrutide clinical trials in United States

26 study records currently list 825 locations in this country, including 134 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
26
Listed locations
825
Recruiting locations
134
Records with local recruiting sites
1
NCT07165028
Study-wide statusRecruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Listed locations
141
Recruiting locations
134
Registry update
2026-07-17
NCT07035093
Study-wide statusActive, not recruiting

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Listed locations
25
Recruiting locations
0
Registry update
2026-07-23
NCT06297603
Study-wide statusActive, not recruiting

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Listed locations
28
Recruiting locations
0
Registry update
2026-07-20
NCT06383390
Study-wide statusActive, not recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Listed locations
205
Recruiting locations
0
Registry update
2026-07-20
NCT06662383
Study-wide statusActive, not recruiting

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

Listed locations
40
Recruiting locations
0
Registry update
2026-07-20
NCT07357415
Study-wide statusActive, not recruiting

A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Listed locations
20
Recruiting locations
0
Registry update
2026-06-09
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United States, or keep Retatrutide fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

Retatrutide in North America

Retatrutide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Retatrutide is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: TRIUMPH-1 Phase 3 study - NCT05929066 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

TRIUMPH-1 Phase 3 study - NCT05929066

TRIUMPH-1 Phase 3 study - NCT05929066 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open TRIUMPH-1 Phase 3 study - NCT05929066 ↗

Drugs@FDA approved drug database

Drugs@FDA approved drug database is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drugs@FDA approved drug database ↗

Locate a state-licensed online pharmacy

Locate a state-licensed online pharmacy is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Locate a state-licensed online pharmacy ↗
United States / Country guide

United States market context.

A US peptide search can surface prescription drugs, compounded preparations, telehealth offers, and laboratory-research materials in one result set. Federal and state records answer different questions, so no single lookup validates every route.

  • FDA’s BeSafeRx directory sends consumers to each state board’s pharmacy-license database and says an unlisted online pharmacy should not be used.
  • Sections 503A and 503B apply different conditions to compounding from bulk drug substances; FDA updates the underlying lists and policies as substances are evaluated.
  • FDA’s peptide-related bulk-substance page identifies limited information or potential safety concerns for several names that also appear in research and wellness marketing.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Start with the seller class

For an online pharmacy claim, use FDA’s state-license directory to reach the relevant board database and match the business, address, and current license before comparing price.

02

Separate the federal record

Check FDA approval, shortage, outsourcing-facility, and bulk-substance records separately; a state pharmacy license does not make every product or compounding claim federally supported.

03

Keep research outside care

A laboratory-research listing is not a prescription pathway. Compare only like-for-like catalog rows and retain the research-only boundary, source date, shipping claim, and evidence-access label.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
TRIUMPH-1 Phase 3 study - NCT05929066ClinicalTrials.gov
02
Drugs@FDA approved drug databaseU.S. Food and Drug Administration
03
Locate a state-licensed online pharmacyU.S. Food and Drug Administration
04
What to know about retatrutideEli Lilly and Company
05
Bulk drug substances used in compoundingU.S. Food and Drug Administration
06
Peptide and other bulk-substance safety risksU.S. Food and Drug Administration
07
Retatrutide study search in United StatesClinicalTrials.gov
08
NCT07165028: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)ClinicalTrials.gov
09
NCT07035093: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back PainClinicalTrials.gov
10
NCT06297603: Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)ClinicalTrials.gov
11
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)ClinicalTrials.gov
12
NCT06662383: A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have ObesityClinicalTrials.gov
13
NCT07357415: A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or OverweightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.